Equity (Tables)

9 Months Ended

Sep. 30, 2018

Equity [Abstract]

Schedule of Common Stock Granted

During the nine months ended September 30, 2018 and 2017, the Company granted common shares to certain employees as follows:

	Nine Months Ended September 30,
	2018		2017
Performance Shares(1)
Shares granted:
Index - 1Q	331,025		106,706
Peer - 1Q	331,019		106,705
Index - 2Q			163,466
Peer - 2Q			163,463
Grant date fair value per share:(2)
Index - 1Q	$	5.81	$	6.82
Peer - 1Q	$	5.37	$	6.34
Index - 2Q			$	4.05
Peer - 2Q			$	4.27
Non-Vested Common Shares:(3)
Shares issued	237,570		237,560
Grant date fair value	$	2,190	$	2,551

(1) The shares vest based on the Company's total shareholder return growth after a three-year measurement period relative to an index and a group of Company peers. Dividends will not be paid on these grants until earned. Once the performance criteria are met and the actual number of shares earned is determined, such shares vest immediately. During the nine months ended September 30, 2018, 116,926 of the 642,029 performance shares issued in 2015 vested.

(2) The fair value of grants was determined at the grant date using a Monte Carlo simulation model.

(3) The shares vest ratably over a three-year service period.

Schedule of Accumulated Other Comprehensive Income (Loss)

A summary of the changes in accumulated other comprehensive income (loss) related to the Company's cash flow hedges is as follows:

	Nine Months Ended September 30,
	2018			2017
Balance at beginning of period	$	1,065		$	(1,033	)
Other comprehensive income before reclassifications	600			581
Amounts of (income) loss reclassified from accumulated other comprehensive income (loss) to interest expense	(1,013		)	962
Balance at end of period	$	652		$	510